Clinical Trials Browser

Phase 2 × Immunotherapy, Adoptive × 30 days × Clear all

NCT06784726 2026-03-13

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse